Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort

Europace

Volumn 14, Issue 2, 2012, Pages 184-190

  Weijs, Bob ^a   Pisters, Ron ^a   Nieuwlaat, Robby ^b   Breithardt, Gnter ^c   Le Heuzey, Jean Yves ^d   Vardas, Panos E ^e   Limantoro, Ione ^a   Schotten, Ulrich ^a   Lip, Gregory Y H ^f   Crijns, Harry J G M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Definition; Idiopathic atrial fibrillation; Prevalence

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTIVITAMIN K;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVERSION; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH SURVEY; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; STROKE;

ADULT; AGE DISTRIBUTION; AGED; ATRIAL FIBRILLATION; COHORT STUDIES; COMORBIDITY; EUROPE; HEART ATRIA; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MIDDLE AGED; ORGAN SIZE; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION;

EID: 84856241625     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur379     Document Type: Article

References (32)

1. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. JAMA 1985; 254:3449-53. (Pubitemid 16148410)
2. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31: 2369-429.
3. Evans W, Swann P. Lone auricular fibrillation. Br Heart J 1954;16:189-94.
4. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM et al.The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987;317:669-74. (Pubitemid 17138192)
5. Levy S. Epidemiology and classification of atrial fibrillation. J Cardiovasc Electrophysiol 1998;9:S78-82. (Pubitemid 28394721)
6. Kozlowski D, Budrejko S, Lip GY, Rysz J, Mikhailidis DP, Raczak G et al. Lone atrial fibrillation: what do we know? Heart 2010;96:498-503.
7. Rienstra M, Hagens VE, Van Veldhuisen DJ, Bosker HA, Tijssen JG, Kamp O et al. Clinical characteristics of persistent lone atrial fibrillation in the RACE study. Am J Cardiol 2004;94:1486-90. (Pubitemid 40268447)
8. Allessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001;103:769-77. (Pubitemid 32144209)
9. Sanfilippo AJ, Abascal VM, Sheehan M, Oertel LB, Harrigan P, Hughes RA et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation 1990;82:792-7. (Pubitemid 20316730)
10. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on atrial fibrillation. Eur Heart J 2005;26:2422-34. (Pubitemid 41552972)
11. Nieuwlaat R, Prins MH, Le Heuzey JY, Vardas PE, Aliot E, Santini M et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J 2008;29: 1181-9. (Pubitemid 351844895)
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108. (Pubitemid 43257193)
13. de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 2010;55:725-31.
14. Kopecky SL, Gersh BJ, McGoon MD, Chu CP, Ilstrup DM, Chesebro JH et al. Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk. Arch Intern Med 1999;159:1118-22. (Pubitemid 29230865)
15. Osranek M, Bursi F, Bailey KR, Grossardt BR, Brown RD Jr, Kopecky SL et al. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J 2005;26:2556-61. (Pubitemid 41679360)
16. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995;92: 835-41.
17. Thomas L, Levett K, Boyd A, Leung DY, Schiller NB, Ross DL. Compensatory changes in atrial volumes with normal aging: is atrial enlargement inevitable? J Am Coll Cardiol 2002;40:1630-5. (Pubitemid 35253641)
18. Gosselink AT, Crijns HJ, Hamer HP, Hillege H, Lie KI. Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease. J Am Coll Cardiol 1993;22:1666-72. (Pubitemid 23336721)
19. Schotten U, de Haan S, Neuberger HR, Eijsbouts S, Blaauw Y, Tieleman R et al. Loss of atrial contractility is primary cause of atrial dilatation during first days of atrial fibrillation. Am J Physiol Heart Circ Physiol 2004;287:H2324-31. (Pubitemid 39430773)
20. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/ AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice uidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:651-745. (Pubitemid 44472247)
21. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-60. (Pubitemid 35341298)
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52. (Pubitemid 37553153)
23. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-6. (Pubitemid 33124327)
24. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010;375:895-905.
25. Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 2009;119:2146-52.
26. Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL et al. Longterm progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 2007;115:3050-6. (Pubitemid 46956493)
27. Fogari R, Mugellini A, Zoppi A, Preti P, Destro M, Lazzari P et al. Effect of Telmisartan and Ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation. J Cardiovasc Pharmacol Ther; Epub ahead of print 18 February 2011, doi:10.1177/ 1074248410395018.
28. Katritsis DG, Toumpoulis IK, Giazitzoglou E, Korovesis S, Karabinos I, Paxinos G et al. Latent arterial hypertension in apparently lone atrial fibrillation. J Interv Card Electrophysiol 2005;13:203-7. (Pubitemid 41367257)
29. Schoonderwoerd BA, Smit MD, Pen L, Van Gelder IC. New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. Europace 2008;10:668-73. (Pubitemid 351775282)
30. Mattioli AV, Bonatti S, Zennaro M, Mattioli G. The relationship between personality, socio-economic factors, acute life stress and the development, spontaneous conversion and recurrences of acute lone atrial fibrillation. Europace 2005;7: 211-20. (Pubitemid 40614356)
31. Mont L, Tamborero D, Elosua R, Molina I, Coll-Vinent B, Sitges M et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace 2008;10:15-20. (Pubitemid 351767264)
32. Rosiak M, Dziuba M, Chudzik M, Cygankiewicz I, Bartczak K, Drozdz J et al. Risk factors for atrial fibrillation: not always severe heart disease, not always so 'lonely'. Cardiol J 2010;17:437-42.